Indiana University Research and Technology Corporation
发明人:
Richard D. DiMarchi,Brian P. Ward
申请号：
US13728110
公开号：
US09249206B2
申请日:
2012.12.27
申请国别(地区):
US
年份:
2016
代理人:
摘要：
Provided herein are glucagon analogs which exhibit potent activity at the GIP receptor, and, as such are contemplated for use in treating diabetes and obesity. In exemplary embodiments, the glucagon analog of the present disclosures exhibit an EC50 at the GIP receptor which is within the nanomolar or picomolar range.
